Remove Initial Public Offering Remove Investment Remove Investment Manager
article thumbnail

Inception Growth Acquisition Limited Announces Extension of Business Combination Period

Global Newswire by Notified: M&A

The purpose of the extension is to provide additional time for the Company to complete a business combination.

article thumbnail

Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024

Cooley M&A

Big pharma dominated life sciences M&A, with more than two-thirds (69%) of M&A investment coming from big pharma, compared to just 38% in 2022. from 2022 to 2023 – which may be attributable to buyers becoming more selective in the types of assets in which they invest and preferring to acquire a company and gain full control.

M&A 52